Apellis Pharmaceuticals, Inc. (APLS)
24.65
+0.17
(+0.69%)
USD |
NASDAQ |
Dec 19, 16:00
25.10
+0.45
(+1.83%)
After-Hours: 20:00
Apellis Pharmaceuticals Shareholders Equity (Annual): 228.54M for Dec. 31, 2024
Shareholders Equity (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Annual) Benchmarks
| Biogen, Inc. | 16.72B |
| Amicus Therapeutics, Inc. | 194.04M |
| Fortress Biotech, Inc. | 22.74M |
| Ultragenyx Pharmaceutical, Inc. | 255.30M |
| Fulcrum Therapeutics, Inc. | 243.03M |